Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors G. J. PetersP. NoordhuisC. J. Van Groeningen Original Article 09 May 2003 Pages: 1 - 12
Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial Joseph T. SantosoJoseph A. Lucci IIIEdward V. Hannigan Original Article 29 April 2003 Pages: 13 - 18
Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial Seiji NihoKaoru KubotaYutaka Nishiwaki Original Article 24 April 2003 Pages: 19 - 24
Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumors Ramesh R. BoinpallyLisa PolinRalph E. Parchment Original Article 09 May 2003 Pages: 25 - 33
A population model of epirubicin pharmacokinetics and application to dosage guidelines Lorraine D. RalphAlison H. ThomsonChris Twelves Original Article 23 May 2003 Pages: 34 - 40
Combined effects of temozolomide and the ribonucleotide reductase inhibitors didox and trimidox in malignant brain tumor cells M. FigulA. SölingN. G. Rainov Original Article 11 April 2003 Pages: 41 - 46
Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3 Xiao-Mei HuToshihiko HiranoKitaro Oka Original Article 16 May 2003 Pages: 47 - 58
An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis Devendra S. DandekarVinata B. LokeshwarBalakrishna L. Lokeshwar Original Article 07 May 2003 Pages: 59 - 66
Phase I and pharmacokinetic study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer M. IchikiR. GoharaH. Aizawa Original Article 13 May 2003 Pages: 67 - 72
Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer Fumihiro OshitaKouzo YamadaHaruhiro Saito Original Article 16 May 2003 Pages: 73 - 78
Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly schedule Xiao-Du GuoNancy HaroldJean L. Grem Original Article 18 April 2003 Pages: 79 - 85
Clinical effects of combination therapy with mitoxantrone, vincristine, and prednisolone in breast cancer Kenji KatsumataHidenori TomiokaYasuhisa Koyanagi Short Communication 23 May 2003 Pages: 86 - 88
